FDA
- States claim economic harm from abortion pill; case revived after doctors’ legal loss
- States have a primary role in keeping women safe from chemical abortion drugs, Heartbeat tells federal appeals court
-
Study suggests abortion pill complications are underreported, and ERs are managing the majority
-
Supreme Court could rule soon on abortion pill regulations
-
Supreme Court refuses to rule on FDA request to keep abortion pill safeguards in place
-
Supreme Court to issue first post-Ginsburg abortion decision on RU-486
- The abortion industry’s ‘very safe’ lie is putting women at very big risk
-
The abortion pill: So dangerous it needs a rare safety requirement
-
The abortion pill’s significant complications must not be buried or ignored
-
The Biden administration is set to make dangerous abortion pills more widely available
- The bottom line of selling mifepristone
-
The day the FDA abandoned the first principle of medical ethics
-
The new reality of abortion in post-Roe America - Separating abortion fact from fiction
-
The ninety-two
-
The package in the mailbox? It’s an abortion.
- The startling reality of forced abortion
-
The worst lie: That weakened safety standards for chemical abortions does not pose a threat to women
-
The “need” for and availability of abortion in post-Roe America
-
Three states sue FDA for allowing abortion pills to be shipped via mail
- Three states sue FDA for ‘disregarding the health and safety’ of women with abortion pill expansion